Rheumatoid Arthritis Shared Decision Making Initiative

Next

To translate novel biologic therapeutics from the bench to the bedside, a recent thread of our RA research involves the assessment of literacy, factors that influence patient decision quality, patient skills to interpret risk, and the development of decision aids to support patient choice.  We have listed only a few of our publications which are linked their abstracts at the National Library of Medicine.

Patient decision-making related to antirheumatic drugs in rheumatoid arthritis: the importance of patient trust of physician. Martin RW, Head AJ, René J, Swartz TJ, Fiechtner JJ, McIntosh BA, Holmes-Rovner M. J Rheumatol. 2008;35(4):618-24. 


An experimental evaluation of patient decision aid design to communicate the effects of medications on the rate of progression of structural joint damage in rheumatoid arthritis. Martin RW, Brower ME, Geralds A, Gallagher PJ, Tellinghuisen DJ.  Patient Educ Couns. 2012;86(3):329-34.


Communicating the risk of side effects to rheumatic patients.  Martin RW.  Rheum Dis Clin North Am. 2012 Nov;38(4):653-62.


Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug.  Martin RW, McCallops K, Head AJ, Eggebeen AT, Birmingham JD, Tellinghuisen DJ. BMC Med Inform Decis Mak. 2013 Aug 12;13:89. doi: 10.1186/1472-6947-13-89.


Explore our patient decision aids which will help guide you though the steps that can lead you to an informed decision that matchs your values. 

©2015 West Michigan Rheumatology, PLLC                1155 East Paris SE, Suite 100                              Grand Rapids, MI 49546                                               Voice 616.459.8088                                                       FAX 616.459.8312                                                www.mi-arthritis.com